Here are three things to know about the offers:
1. KKR beat the eight other bidders with its $46 per share offer. Envision and KKR entered into a definitive agreement June 11 for their all-cash transaction, which includes the assumption of debt.
2. The highest offer came from an undisclosed “bidder nine,” who indicated a price range of $53 to $60 per share. In addition, four industry participants and one financial sponsor submitted preliminary offers to acquire Envision’s ASC business, valuing the company between $2.5 billion and $3.5 billion.
3. Private equity firms are playing a bigger role in healthcare deal-making. So far this year, roughly nine private equity firms have made a bid for or acquired a healthcare company’s business.
More articles on transactions and valuations:
9 private equity firms gobbling up healthcare businesses
Beth Israel, Lahey merger faces pushback from attorney general
6-hospital California system explores sale to ease financial pressure
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
